Nutron Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.48 M
- Company Age 34 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 15.00 Cr
- Satisfied Charges ₹ 26.94 Cr
- Revenue Growth -37.72%
- Profit Growth -49.46%
- Ebitda -63.43%
- Net Worth 8.70%
- Total Assets 11.18%
About Nutron Pharmaceuticals
Nutron Pharmaceuticals Private Limited (NPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 12 October 1990 and has a history of 34 years and three months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.48 M.
The company currently has active open charges totaling ₹15.00 Cr. The company has closed loans amounting to ₹26.94 Cr, as per Ministry of Corporate Affairs (MCA) records.
Dinesh Shah, Jayesh Shah, Ramesh Shah, and Four other members serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230MH1990PTC058515
-
Company No.
058515
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Oct 1990
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Nutron Pharmaceuticals?
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Praful Shah
|
Director | 18-Oct-2012 | Current |
|
Dinesh Shah
|
Director | 15-Mar-1999 | Current |
|
Jayesh Shah
|
Director | 15-Mar-1999 | Current |
|
Ramesh Shah
|
Director | 12-Oct-1990 | Current |
|
Manish Shah
|
Director | 03-Apr-1995 | Current |
|
Popatlal Shah
|
Director | 12-Oct-1990 | Current |
Financial Performance of Nutron Pharmaceuticals.
Nutron Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 37.72% decrease. The company also saw a substantial fall in profitability, with a 49.46% decrease in profit. The company's net worth moved up by a moderate rise of 8.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nutron Pharmaceuticals?
In 2023, Nutron Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Terrapolis Buildcon Private LimitedJayesh Shah, Manish Shah and 1 more are mutual person
-
Mehal Enterprise Llp
Ramesh Shah and Ritesh Shah are mutual person
-
New Dholera Shipping & Trading Co Limited
Ritesh Shah is a mutual person
-
New Dholera Corporealty Private Limited
Ritesh Shah is a mutual person
Charges (Loans)
₹150.00 M
₹269.43 M
Charges Breakdown by Lending Institutions
- Others : 15.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jan 2021 | Others | ₹15.00 Cr | Open |
| 15 Feb 2008 | Citi Bank N.A. | ₹22.50 Cr | Satisfied |
| 05 Mar 2007 | Citibank N.A. | ₹2.50 Cr | Satisfied |
| 17 Sep 2003 | The Sangli Bank Limited | ₹1.50 Cr | Satisfied |
| 28 Jul 1998 | Bank Of Madura Ltf | ₹0.93 M | Satisfied |
How Many Employees Work at Nutron Pharmaceuticals?
Unlock and access historical data on people associated with Nutron Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nutron Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nutron Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.